Bessemer Group Inc. lifted its holdings in shares of ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) by 52.

Canaccord Genuity analyst Gary Nachman initiates coverage on ANI Pharmaceuticals (NASDAQ:ANIP) wi

ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) (ANI or the Company) today announced that Judge Sheldon K. R

Trial court denied Company’s motion for a new trial and judgment as a matter of law for unjust enric

PRINCETON, N.J., July 16, 2026 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or

ANI Pharmaceuticals Inc (NASDAQ:ANIP) reported positive topline data from a Phase 4 trial of its flu

ANI Pharmaceuticals Inc (NASDAQ:ANIP) reported positive topline data from a Phase 4 trial of its flu

ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) (ANI or the Company) today announced positive topline data f

PRINCETON, N.J., July 13, 2026 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or

The executive disposed of 3,313 shares on July 2, 2026, for a total transaction value of about $285,

Guggenheim analyst Vamil Divan reiterates ANI Pharmaceuticals (NASDAQ:ANIP) with a Buy and mainta

An ANI Pharmaceuticals executive reported selling 2,850 shares directly for about $240,000 on June 2

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further t

ANI Pharmaceuticals is rated a speculative buy, with the investment thesis centered on Cortrophin Ge

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further t

ANIP trades at 9.75x forward earnings after raising 2026 guidance, but investors must weigh Cortroph

ANIP expands Cortrophin into acute gout flares with a 90-person sales force as investors watch adopt

ANI Pharmaceuticals ANIP is reshaping its growth profile. In 2025, revenue surged on the back of a r

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the

PRINCETON, N.J., May 27, 2026 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or t

ANIP leans into rare disease growth as Cortrophin and Iluvien drive specialty momentum, while 2026 f

ANI Pharmaceuticals trades at 9.83x forward earnings, far below peers and its five-year median despi

Cortrophin Gel is reshaping ANI Pharmaceuticals into a specialty-driven growth story, with 2026 reve

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the

ANI Pharmaceuticals develops and manufactures branded and generic drugs for diverse North American h

ANI Pharmaceuticals (NASDAQ:ANIP) raises FY2026 Adj EPS guidance from $8.83-$9.34 to $9.19-$9.69 vs

ANI Pharmaceuticals (NASDAQ:ANIP) reported quarterly earnings of $2.05 per share which beat the anal

ANI Pharmaceuticals, Inc. (ANI or the Company) (NASDAQ: ANIP) today announced the launch of Pimozide

ANI Pharmaceuticals, Inc. (ANI or the Company) (NASDAQ:ANIP) today announced that following final ap

ANI Pharmaceuticals, Inc. (ANI or the Company) (NASDAQ:ANIP) today announced publication of the resu

Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is expected to report earnings for

Stocks That Hit 52-Week Lows On Monday

Stocks That Hit 52-Week Lows On Thursday

Stocks That Hit 52-Week Lows On Friday

Stocks That Hit 52-Week Lows On Thursday

Stocks Which Set New 52-Week Low Yesterday, October 31st